RU93056837A - Гексагидронафталиновые сложноэфирные производные, способы их получения и фармацевтическая композиция - Google Patents
Гексагидронафталиновые сложноэфирные производные, способы их получения и фармацевтическая композицияInfo
- Publication number
- RU93056837A RU93056837A RU93056837/04A RU93056837A RU93056837A RU 93056837 A RU93056837 A RU 93056837A RU 93056837/04 A RU93056837/04 A RU 93056837/04A RU 93056837 A RU93056837 A RU 93056837A RU 93056837 A RU93056837 A RU 93056837A
- Authority
- RU
- Russia
- Prior art keywords
- group
- hexahydronaphthaline
- complex
- production
- methods
- Prior art date
Links
- IKAACYWAXDLDPM-UHFFFAOYSA-N 1,2,3,4,4a,5-hexahydronaphthalene Chemical compound C1=CCC2CCCCC2=C1 IKAACYWAXDLDPM-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 206010007541 Cardiac disease Diseases 0.000 claims 1
- 229940107161 Cholesterol Drugs 0.000 claims 1
- 208000009576 Hypercholesterolemia Diseases 0.000 claims 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 claims 1
- 230000002194 synthesizing Effects 0.000 claims 1
Claims (1)
- Предложены соединения формулы I
в которой R1 представляет собой группу формулы II или III
R2 - алкильная, алкенильная или алкинильная группы, каждая из групп R3 и R4 - водород, алкильная, алкенильная или алкинильная группа, R5 - водород или карбоксизащищенная группа, Rа - водород или группа формулы -OR6, каждая из групп R6, R6 а и R6 b - водород, гидроксизащищающая группа, алкильная, алкансульфонильная, галоидированная алкансульфонильная или арилсульфонильная группа] и их соли и сложные эфиры обладают способностью ингибировать синтез холестерина и таким образом могут использоваться для лечения и профилактики гиперхолестеринемии и различных сердечных расстройств.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4-349034 | 1992-12-28 | ||
JP34903492 | 1992-12-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93056837A true RU93056837A (ru) | 1996-12-27 |
RU2104997C1 RU2104997C1 (ru) | 1998-02-20 |
Family
ID=18401049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93056837A RU2104997C1 (ru) | 1992-12-28 | 1993-12-27 | Гексагидронафталиновые сложноэфирные соединения и фармацевтическая композиция |
Country Status (23)
Country | Link |
---|---|
US (2) | US5451688A (ru) |
EP (1) | EP0605230B1 (ru) |
JP (1) | JPH06247894A (ru) |
KR (1) | KR100286596B1 (ru) |
CN (1) | CN1039642C (ru) |
AT (1) | ATE157346T1 (ru) |
AU (1) | AU670468B2 (ru) |
CA (1) | CA2112442A1 (ru) |
CZ (1) | CZ280492B6 (ru) |
DE (1) | DE69313427T2 (ru) |
DK (1) | DK0605230T3 (ru) |
ES (1) | ES2108238T3 (ru) |
FI (1) | FI935895A (ru) |
GR (1) | GR3025412T3 (ru) |
HK (1) | HK1000937A1 (ru) |
HU (1) | HU221845B1 (ru) |
IL (1) | IL108194A (ru) |
MX (1) | MX9400060A (ru) |
NO (1) | NO300730B1 (ru) |
NZ (1) | NZ250609A (ru) |
RU (1) | RU2104997C1 (ru) |
TW (1) | TW289753B (ru) |
ZA (1) | ZA939741B (ru) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0251582A (ja) * | 1988-08-12 | 1990-02-21 | Kyokado Eng Co Ltd | 地盤注入用薬液 |
US5989877A (en) * | 1995-08-03 | 1999-11-23 | Gist-Brocades B.V. | Selective process for the deacylation of acylated compounds |
KR100186758B1 (ko) * | 1996-08-09 | 1999-04-01 | 영진약품공업 주식회사 | 프라바스타틴(pravastatin)전구체의제조방법 |
CA2226996C (en) * | 1997-01-24 | 2006-08-15 | Kose Corporation | Whitening cosmetic composition comprising polyhydric alcohol |
ES2306482T3 (es) | 1997-08-28 | 2008-11-01 | Novartis Ag | Antagonistas de antigeno-1 funcion con funcion de linfocito. |
US6682913B1 (en) | 1999-02-03 | 2004-01-27 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
CO5140104A1 (es) * | 1999-02-16 | 2002-03-22 | Novartis Ag | Derivados de mevinolina y preparacion farmaceuticas que los contienen |
DK1265604T3 (da) * | 1999-11-30 | 2007-02-05 | Teva Gyogyszergyar Zartkoeruee | Proces til udvinding af statinforbindelser fra en gæringsvæske |
IL150187A0 (en) | 1999-12-14 | 2002-12-01 | Biogal Pharmaceutical Co Ltd | Novel forms of pravastatin sodium |
KR20030059173A (ko) * | 2000-10-05 | 2003-07-07 | 비오갈 기오기스제르갸르 알티. | 프라바스타틴 락톤과 에피-프라바스타틴을 실질적으로함유하지 않는 프라바스타틴 나트륨, 및 이를 포함하는조성물 |
JP2002121172A (ja) * | 2000-10-16 | 2002-04-23 | Sankyo Co Ltd | プラバスタチン又はその薬理上許容される塩の精製方法 |
JP3236282B1 (ja) * | 2000-10-16 | 2001-12-10 | 三共株式会社 | プラバスタチンを精製する方法 |
KR100458151B1 (ko) * | 2001-05-14 | 2004-11-26 | 씨제이 주식회사 | 프락토실 트랜스퍼라제를 생산하는 신규 미생물 및 이를이용하여 프락토올리고당 및 네오프락토올리고당을생산하는 방법 |
ITMI20021327A1 (it) * | 2002-06-14 | 2003-12-15 | Recordati Chem Pharm | Nuove ossialchilpiperazine |
US7071197B2 (en) | 2002-06-14 | 2006-07-04 | Recordati S.A. | N,N-disubstituted diazocycloalkanes |
US7029178B2 (en) * | 2002-10-04 | 2006-04-18 | Ght Ventures, Llc | Zip-lock closure |
US7425644B2 (en) * | 2003-11-24 | 2008-09-16 | TEVA Gyógyszergyár Zártkörűen Működő Részvénytársaság | Method of purifying pravastatin |
CN1277826C (zh) * | 2003-12-01 | 2006-10-04 | 叶红平 | 辉伐他汀及其合成方法和以辉伐他汀为原料药的制剂 |
US20070185193A1 (en) * | 2003-12-01 | 2007-08-09 | Huaibei Huike Pharmaceutical, Co. Ltd. | Huvastatin and its preparation and formulation comprising the huvastatin |
WO2005121062A2 (en) * | 2004-06-09 | 2005-12-22 | Ranbaxy Laboratories Limited | Process for the preparation of pravastatin |
RU2007115522A (ru) * | 2004-10-12 | 2008-10-27 | Декод Дженетикс Ехф (Is) | Пери-замещенные бициклические карбоновые кислоты для лечения окклюзионного заболевания артерий |
TWI307360B (en) | 2004-12-03 | 2009-03-11 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Process for constructing strain having compactin hydroxylation ability |
US20090068325A1 (en) * | 2007-09-10 | 2009-03-12 | Gil Depicciotto | Method of treatment of fresh produce |
EP2241561A1 (en) * | 2009-04-16 | 2010-10-20 | Neuron Biopharma, S.A. | Neuroprotective, hypocholesterolemic and antiepileptic compound |
ES2380473B1 (es) * | 2010-10-13 | 2013-02-19 | Neuron Biopharma, S.A. | Compuesto neuroprotector, hipocolesterolémico, antiinflamatorio y antiepiléptico. |
EP2977381B1 (en) | 2013-03-19 | 2018-09-26 | Daiichi Sankyo Company, Limited | Terpenoid derivative |
CN108546721B (zh) * | 2018-04-20 | 2021-04-13 | 安徽大学 | 一种利用微生物合成对羟基苯甲酸的方法 |
US20240150279A1 (en) * | 2021-02-01 | 2024-05-09 | The University Of Toledo | C prime agents for treating metabolic disorders |
CN114250254B (zh) * | 2021-12-20 | 2024-01-05 | 宁夏清研高分子新材料有限公司 | 一种对羟基苯甲酸的微生物合成方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH381478A (de) * | 1959-11-21 | 1964-08-31 | Atkinsons Agricultural Appl | Sicherheitsschutzvorrichtung für Gelenkwellenkupplungen |
DE2748825C2 (de) * | 1976-11-02 | 1986-11-27 | Sankyo Co., Ltd., Tokio/Tokyo | Substituierte 3,5-Dihydroxyheptansäurederivate und diese enthaltende Arzneimittel gegen Hyperlipämie |
AU548996B2 (en) * | 1980-02-04 | 1986-01-09 | Merck & Co., Inc. | Tetrahydro-2h-pyran-2-one derivatives |
MX7065E (es) * | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
JPS5810572A (ja) * | 1981-07-07 | 1983-01-21 | Sankyo Co Ltd | Ml−236b誘導体およびその製造法 |
JPS5889191A (ja) * | 1981-11-20 | 1983-05-27 | Sankyo Co Ltd | 3−ヒドロキシ−ml−236b誘導体の製造法 |
JPS5917545A (ja) * | 1982-07-22 | 1984-01-28 | Canon Inc | オ−トフオ−カスカメラの距離表示機構 |
JPS59175450A (ja) * | 1983-03-24 | 1984-10-04 | Sankyo Co Ltd | Ml−236b誘導体 |
US4997848A (en) * | 1987-10-27 | 1991-03-05 | Sankyo Company, Limited | Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition |
US5049696A (en) * | 1988-04-11 | 1991-09-17 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
EP0381478A1 (en) * | 1989-02-01 | 1990-08-08 | Merck & Co. Inc. | Process for the preparation of 6-alpha-hydroxymethyl lovastatin derivatives |
GB8915280D0 (en) * | 1989-07-04 | 1989-08-23 | British Bio Technology | Compounds |
GB9007738D0 (en) * | 1990-04-05 | 1990-06-06 | British Bio Technology | Compounds |
GB9100174D0 (en) * | 1991-01-04 | 1991-02-20 | British Bio Technology | Compounds |
IL108432A (en) * | 1993-01-29 | 1997-09-30 | Sankyo Co | DERIVATIVES OF 3, 5-DIHYDROXY-7- £1, 2, 6, 7, 8, 8a-HEXAHYDRO-2- METHYL-8- (SUBSTITUTED ALKANOYLOXY)-1-NAPHTHYL| HEPTANOIC ACID AND THEIR LACTONES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
1993
- 1993-12-23 NZ NZ250609A patent/NZ250609A/xx unknown
- 1993-12-24 DE DE69313427T patent/DE69313427T2/de not_active Expired - Fee Related
- 1993-12-24 ES ES93310536T patent/ES2108238T3/es not_active Expired - Lifetime
- 1993-12-24 CA CA002112442A patent/CA2112442A1/en not_active Abandoned
- 1993-12-24 EP EP93310536A patent/EP0605230B1/en not_active Expired - Lifetime
- 1993-12-24 AU AU52699/93A patent/AU670468B2/en not_active Ceased
- 1993-12-24 DK DK93310536.3T patent/DK0605230T3/da active
- 1993-12-24 AT AT93310536T patent/ATE157346T1/de not_active IP Right Cessation
- 1993-12-27 CZ CZ932900A patent/CZ280492B6/cs unknown
- 1993-12-27 NO NO934852A patent/NO300730B1/no unknown
- 1993-12-27 IL IL108194A patent/IL108194A/en active IP Right Grant
- 1993-12-27 HU HU9303762A patent/HU221845B1/hu not_active IP Right Cessation
- 1993-12-27 TW TW082111024A patent/TW289753B/zh active
- 1993-12-27 RU RU93056837A patent/RU2104997C1/ru not_active IP Right Cessation
- 1993-12-28 ZA ZA939741A patent/ZA939741B/xx unknown
- 1993-12-28 CN CN93121768A patent/CN1039642C/zh not_active Expired - Fee Related
- 1993-12-28 KR KR1019930030497A patent/KR100286596B1/ko not_active IP Right Cessation
- 1993-12-28 US US08/174,661 patent/US5451688A/en not_active Expired - Fee Related
- 1993-12-28 JP JP5335405A patent/JPH06247894A/ja active Pending
- 1993-12-28 FI FI935895A patent/FI935895A/fi unknown
-
1994
- 1994-01-03 MX MX9400060A patent/MX9400060A/es not_active IP Right Cessation
-
1995
- 1995-12-28 US US08/579,840 patent/US5827855A/en not_active Expired - Fee Related
-
1997
- 1997-11-19 GR GR970403057T patent/GR3025412T3/el unknown
- 1997-12-23 HK HK97102563A patent/HK1000937A1/xx not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU93056837A (ru) | Гексагидронафталиновые сложноэфирные производные, способы их получения и фармацевтическая композиция | |
NO821494L (no) | Terapeutisk nyttige 1-alkyl-2-aminotetralinderivater | |
LU90053I2 (fr) | Topotecan et ses sels et dérivés pharmaceutiquement acceptables (Hycamtin) | |
RU96117041A (ru) | Применение производных 2-гидрокси-5-фенилазобензойной кислоты в качестве химиопрофилактических и химиотерапевтических агентов при раке ободочной кишки | |
RU93005057A (ru) | Фармацевтические соединения, производные тиенобензодиазепина, способ их получения, фармкомпозиция и их использование | |
NO934852D0 (no) | Hexahydronafthalenesterderivater, deres fremstilling og terapeutiske anvendelse | |
ES8700660A1 (es) | Un procedimiento para la preparacion de derivados de bencimidasol. | |
ATE81655T1 (de) | Cephemverbindungen und verfahren zu ihrer herstellung. | |
ATE99934T1 (de) | Heteroaryl-3-oxo-propannitril-derivate, nuetzlich zur behandlung von rheumatoider arthritis und anderen autoimmunkrankheiten. | |
ATE5961T1 (de) | N-acylpeptid-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
ATE63541T1 (de) | N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel. | |
RU94002313A (ru) | Эфирные производные гексагидронафталина, их получение и фармацевтическая композиция на их основе | |
NO933091L (no) | Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser | |
HUT67938A (en) | 1,3,4-thiadiazin-2-one derivatives, pharmaceutical compositions containing them and their preparation | |
DE69110217D1 (de) | Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen. | |
DK0609058T3 (da) | Hexahydronaphthalenesterderivater, deres fremstilling og deres terapeutiske anvendelse | |
TNSN86099A1 (fr) | Nouveaux benzamides, leur procede de preparation et leur application dans le domaine therapeutique | |
ATE79618T1 (de) | Thiadiazolguanidine. | |
KR950032151A (ko) | 점착성 수용체 길항제 | |
ES2005778A6 (es) | Procedimiento para la obtencion de derivados de diisobutilxantina. | |
RU93005202A (ru) | Производные пиримидина и лекарственное средство | |
EP0314008A3 (en) | N-substituted aliphatic heterocyclic compounds able to facilitate the passage of active substances through physiological barriers |